Description:
Levosalbutamol 0.31 mg belongs to a class of medications known as fast-acting bronchodilators or reliever therapies. It is primarily used to treat and relieve symptoms associated with asthma and chronic obstructive pulmonary disease (COPD), including coughing, wheezing, chest tightness, and shortness of breath. Administered via nebulisation, it offers rapid relief by relaxing the airway muscles and improving airflow to the lungs.
Therapeutic Uses:
Acute relief of bronchospasm in asthma
Symptomatic treatment of COPD, including chronic bronchitis and emphysema
Management of respiratory distress during exacerbations
Mechanism of Action:
Levosalbutamol selectively stimulates beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation. This relaxes the airways, allowing for easier breathing and rapid symptom relief.
Dosage Form:
Nebuliser solution
Strength:
0.31 mg per unit dose
Prescription Status:
Prescription-only medication
Note:
Levosalbutamol 0.31 mg is intended for short-term, as-needed use during episodes of breathing difficulty. It should be used under the supervision of a healthcare professional, and is not a substitute for long-term maintenance therapy. Proper nebulisation technique is essential for effective delivery.
Would you like this adapted for a pharmacy label, export datasheet, or digital catalog?
